Gsa Capital Partners LLP Shockwave Medical, Inc. Transaction History

Gsa Capital Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 16, 2024	SELL	$160.99 - $215.69 $157,126 - $210,513	-976 Reduced 36.9%	1,669 $318,000
Q3 2023 Nov 15, 2023	BUY	$194.33 - $283.97 $89,391 - $130,626	460 Added 21.05%	2,645 $526,000
Q2 2023 Aug 14, 2023	BUY	$223.05 - $302.68 $487,364 - $661,355	2,185 New	2,185 $623,000
Q4 2022 Feb 13, 2023	BUY	$204.38 - $296.82 $404,468 - $587,406	1,979 New	1,979 $407,000
Q4 2020 Feb 03, 2021	SELL	$67.44 - $103.72 $1.45 Million - $2.23 Million	-21,504 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$42.79 - $75.8 $920,156 - $1.63 Million	21,504 New	21,504 $1.63 Million
Q4 2019 Feb 12, 2020	SELL	$29.4 - $44.98 $370,116 - $566,253	-12,589 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$29.71 - $55.23 $374,019 - $695,290	12,589 New	12,589 $377,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.